Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2012, Article ID 783696, 6 pages
http://dx.doi.org/10.1155/2012/783696
Research Article

Cognition and Vascular Risk Factors: An Epidemiological Study

1Department of Internal Medicine, Cardiovascular Division, Hospital Español de Buenos Aires, Argentina
2Argentine Federation of Cardiology (AFC), Buenos Aires, Argentina
3Research Group, Human Health Commission, CERTUS Foundation, Villa María, Córdoba, Argentina
4School Medicine, National University of Córdoba, Córdoba, Argentina
5School of Public Health, School Medicine, National University of Córdoba, Córdoba, Argentina

Received 17 May 2012; Revised 16 July 2012; Accepted 23 July 2012

Academic Editor: Rafael Hernández-Hernández

Copyright © 2012 Augusto Vicario et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Alzheimer’s disease International, “World Alzheimer Report 2009–2011,” 2012, http://www.alz.co.uk/research/world-report.
  2. L. J. Launer, “Demonstrating the case that AD is a vascular disease: epidemiologic evidence,” Ageing Research Reviews, vol. 1, no. 1, pp. 61–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. De la Torre, “Alzheimer disease as a vascular disorder: nosological evidence,” Stroke, vol. 33, no. 4, pp. 1152–1162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Shing-Manoux, M. Kivimaki, M. M. Glymour et al., “Timing of onset of cognitive decline: result from Whitehall II prospective cohort study,” British Medical Journal, vol. 344, Article ID d7622, 2012. View at Publisher · View at Google Scholar
  5. Ministerio de Salud de la Nación, “Presidencia de la Nación. Encuesta Nacional de Factores de Riesgo (ENFR). Para enfermedades no transmisibles,” 2012, http://msal.gov.ar/htm/site/enfr/que_aspectos.asp.
  6. Consejo Argentino de Hipertensión Arterial, ““Dr. Eduardo Braun Menéndez”: consenso de hipertensión arterial,” Revista Argentina de Cardiología, vol. 75, supplement 4, pp. S1–S43, 2007. View at Google Scholar
  7. G. Mancia, G. De Backer, A. Dominiczak et al., “2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension,” Journal of Hypertension, vol. 25, no. 9, pp. 1751–1762, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Grundy, H. B. Brewer Jr., J. I. Cleeman, S. C. Smith, and C. Lenfant, “Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition,” Circulation, vol. 109, no. 3, pp. 433–438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. G. M. M. Alberti and P. Z. Simmet, “Definition, diagnosis and classification of diabetes mellitus and its complications—part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, pp. 539–553, 1998. View at Google Scholar
  10. A. S. Zigmond and R. P. Snaith, “The hospital anxiety and depression scale,” Acta Psychiatrica Scandinavica, vol. 67, no. 6, pp. 361–370, 1983. View at Google Scholar · View at Scopus
  11. A. Vicario, G. H. Cerezo, F. E. Taragano et al., “Evaluación, diagnostico y tratamiento de los trastornos cognitivos en pacientes con enfermedad vascular. Recomendaciones para la práctica clínica 2007,” Revista de la Federacion Argentina de Cardiologia, vol. 36, supplement 3, pp. S1–S30.
  12. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “'Mini mental state'. A practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar · View at Scopus
  13. R. F. Allegri, J. A. Ollari, C. A. Mangone et al., “El “Mini Mental Statement Examination” en la Argentina: instrucciones para su administración,” Revista Neurológica Argentina, vol. 24, pp. 31–35, 1999. View at Google Scholar
  14. C. M. Serrano, R. F. Allegri, M. Drake et al., “Versión corta en español del test de denominación de Boston: su utilidad en el diagnóstico diferencial de la en enfermedad de Alzheimer,” Revista de Neurología, vol. 33, pp. 624–627, 2001. View at Google Scholar
  15. T. A. Salthouse, “When does age-related cognitive decline begin?” Neurobiology of Aging, vol. 30, no. 4, pp. 507–514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. K. Elias, M. F. Elias, M. A. Robbins, and M. M. Budge, “Blood pressure-related cognitive decline: does age make a difference?” Hypertension, vol. 44, no. 5, pp. 631–636, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Vicario, C. D. Martinez, D. Baretto, A. Diaz Casale, and L. Nicolosi, “Hypertension and cognitive decline: impact on executive function,” Journal of Clinical Hypertension, vol. 7, no. 10, pp. 598–604, 2005. View at Google Scholar · View at Scopus
  18. A. Vicario, M. Del Sueldo, J. Zilberman, and G. H. Cerezo, “Cognitive evolution in hypertensive patients: a six-year follow-up,” Vascular Health and Risk Management, vol. 7, pp. 1–5, 2011. View at Google Scholar
  19. E. Duron and O. Hanon, “Vascular risk factors, cognitve decline, and dementia,” Vascular Health and Risk Management, vol. 4, no. 2, pp. 363–381, 2008. View at Google Scholar · View at Scopus
  20. J. A. Luchsinger, C. Reitz, L. S. Honig, M. X. Tang, S. Shea, and R. Mayeux, “Aggregation of vascular risk factors and risk of incident Alzheimer disease,” Neurology, vol. 65, no. 4, pp. 545–551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. M. Mielke, P. B. Rosenberg, J. Tschanz et al., “Vascular factors predict rate of progression in Alzheimer disease,” Neurology, vol. 69, no. 19, pp. 1850–1858, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Hachinski and D. G. Muñoz, “Cerebrovascular pathology in Alzheimer’s disease: cause, effect or epiphenomenon?” Annals of the New York Academy of Sciences, vol. 11, supplement 1, pp. 23–28, 1997. View at Google Scholar
  23. L. White, H. Petrovitch, J. Hardman et al., “Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants,” Annals of the New York Academy of Sciences, vol. 977, pp. 9–23, 2002. View at Google Scholar · View at Scopus
  24. A. Vicario and C. D. Martinez, “Evaluación del daño funcional del cerebro en pacientes hipertensos: empleo del Examen Cognitivo Mínimo,” Revista de la Federacion Argentina de Cardiologia, vol. 36, pp. 146–151, 2007. View at Google Scholar
  25. I. Skoog, B. Lernfelt, S. Landahl et al., “15-year longitudinal study of blood pressure and dementia,” Lancet, vol. 347, no. 9009, pp. 141–145, 1996. View at Google Scholar · View at Scopus
  26. L. J. Launer, G. W. Ross, H. Petrovitch et al., “Midlife blood pressure and dementia: the Honolulu-Asia aging study,” Neurobiology of Aging, vol. 21, no. 1, pp. 49–55, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Kivipelto, E. L. Helkala, M. P. Laakso et al., “Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study,” British Medical Journal, vol. 322, no. 7300, pp. 1447–1451, 2001. View at Google Scholar · View at Scopus
  28. R. Brookmeyer, S. Gray, and C. Kawas, “Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset,” American Journal of Public Health, vol. 88, no. 9, pp. 1337–1342, 1998. View at Google Scholar · View at Scopus